Haemophilus Influenzae (Hib) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine
Conditions: Diphtheria; Hepatitis B; Haemophilus Influenzae Type b Disease; Poliomyelitis; Pertussis; TetanusIntervention: Biological: Infanrix hexa™Sponsors: GlaxoSmithKline; GlaxoSmithKlineCompleted - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2011 Category: Research Source Type: clinical trials
Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine
Conditions: Poliomyelitis; Tetanus; Acellular Pertussis; Haemophilus Influenzae Type b; Diphtheria; Hepatitis BIntervention: Biological: Infanrix hexa™Sponsor: GlaxoSmithKlineCompleted - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2011 Category: Research Source Type: clinical trials
Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine
Conditions: Diphtheria; Hepatitis B; Haemophilus Influenzae Type b Disease; Poliomyelitis; Pertussis; TetanusIntervention: Biological: Infanrix hexa™Sponsors: GlaxoSmithKline; GlaxoSmithKlineCompleted - verified April 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2011 Category: Research Source Type: clinical trials
Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine
Conditions: Diphtheria; Hepatitis B; Haemophilus Influenzae Type b Disease; Poliomyelitis; Pertussis; TetanusIntervention: Biological: Infanrix hexa™Sponsors: GlaxoSmithKline; GlaxoSmithKlineActive, not recruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2011 Category: Research Source Type: clinical trials